Statistics on Biotechnology Use Results by sector of operation Company sector. Biotechnology results by main variables by whichever Biotechnology activities are the main ones, secondary or a tool necessary for production Unidades: specified in variables Total Main Secondary dwellings Tool Companies that carry out R&D in Biotechnology 1.133 603 173 357 %Companies according to biotechnology used: Genetic code 33 39 28 25 %Companies according to biotechnology used: Functional units 41 44 39 36 %Companies according to biotechnology used: Cellular and tissue culturing and engineering 24 29 19 17 %Companies according to biotechnology used: Bioprocesses 50 45 42 61 %Companies according to biotechnology used: Sub-cellular organisms 6 8 5 3 %Companies according to biotechnology used: Bio-computing 24 33 19 12 %Companies according to biotechnology used: Nanobiotechnology 13 17 15 6 %Companies according to biotechnology used: Other 14 16 16 11 %Company by field(s) of ultimate application of biotechnology use: Human Health 45 59 41 24 %Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture 18 21 14 13 %Company by field(s) of ultimate application of biotechnology use: Food products 31 25 28 43 %Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production 22 19 27 26 %Company by field(s) of ultimate application of biotechnology use: Environment 14 11 22 13 %Company by field(s) of ultimate application of biotechnology use: Industry 12 13 16 8 Personnel in R&D in biotechnology (no. of persons) 11.510 6.862 1.521 3.127 Personnel in R&D in biotechnology (no. of persons): Researchers 6.202 3.759 900 1.543 Personnel in R&D in biotechnology (no. of persons): Technicians and assistants 5.308 3.103 621 1.584 Personnel in R&D in biotechnology (no. of persons): women 6.389 4.015 750 1.624 Personnel in R&D in biotechnology (no. of persons): (women) Researchers 3.304 2.079 442 783 Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants 3.086 1.937 308 841 Personnel in R&D in biotechnology (FTE) 8.236,9 5.430,2 989,7 1.817 Personnel in R&D in biotechnology (FTE): Researchers 4.596,1 3.001,4 642,6 952,1 Personnel in R&D in biotechnology (FTE): Technicians and assistants 3.640,8 2.428,8 347,1 864,9 Personnel in R&D in biotechnology (FTE): women 4.698,5 3.180,1 503,1 1.015,3 Personnel in R&D in biotechnology (FTE): (women) Researchers 2.512,5 1.684,7 323,4 504,4 Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants 2.186 1.495,4 179,7 510,9 Internal expenditure on R&D (thousands of euros) 769.431 541.881 63.951 163.599 1) By nature of the expense: Current expenses 719.715 502.430 60.603 156.683 1.1) Remuneration to researchers 221.447 151.282 26.154 44.011 1.2) Remuneration to technicians and assistants 122.809 83.753 10.469 28.587 1.3) Other current expenses 375.459 267.396 23.979 84.084 2) By nature of the expense: Capital expenses 49.715 39.451 3.348 6.916 2.1) Land and buildings 9.521 7.987 676 858 2.2) Equipment and instruments 30.466 22.742 2.475 5.248 2.3) Acquisition of specific R+D software 1.810 1.212 89 509 2.4) Otros productos de propiedad intelectual específicos para I+D 7.919 7.510 108 301 1.1) By origin of the funds: Own funds 490.913 347.382 40.321 103.210 1.2) By origin of the funds: From companies 82.548 62.516 5.356 14.676 1.3) By origin of the funds: Public Administration funds 96.809 67.645 12.905 16.259 1.4) By origin of the funds: From Universities 197 193 0 4 1.5) By origin of the funds: From non profit private institutions 4.766 1.422 0 3.344 1.6) By origin of the funds: Foreign funds 94.197 62.723 5.369 26.106 Purchase of R&D services in biotechnology (thousands of euros) 120.281 102.804 9.714 7.763 Purchase of R&D services in biotechnology (thousands of euros): In Spain 69.564 57.335 8.455 3.773 Purchase of R&D services in biotechnology (thousands of euros): Abroad 50.718 45.469 1.259 3.990 %Companies that consider the following obstacles as very important considering biotechnology development: Access to capital 45 52 42 35 %Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information 12 9 17 16 %Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources 16 14 20 18 %Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain 14 14 16 12 %Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets 16 16 20 14 %Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels 18 20 18 16 %Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception 15 15 18 15 %Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements 37 39 38 32 %Companies that consider the following obstacles as very important considering biotechnology development : Time / cost 52 54 56 46 %Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting 20 20 21 20 % Companies that have requested biotechnology patents 15 21 11 7 Number of patents requested 681 485 100 96 % Companies with income of an international origin related to biotechnological activities 24,3 34,1 12,6 13,5 % Turnover representing income of an international origin related to biotechnological activities 1 9 0 1 % Income of of an international origin related to biotechnological activities distributed in: Income received from the EU 59,6 60,2 79,3 54,7 % Income of of an international origin related to biotechnological activities distributed in: Income received from other countries 40,4 39,8 20,7 45,4 % Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services 80,4 78,5 17,9 96,8 % Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain 16,5 19,3 0,6 1,4 % Income of an international origin related with activities according to the classification: Operating source abroad 2,2 1,3 70,4 1,8 % Income of an international origin related with activities according to the classification: Other 0,9 0,9 11,1 0 Notas: '.'=numeric piece of data equal to zero not resulting from rounding FTE: Full Time Equivalent Fuente: National Statistics Institute